Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $42.9 million.

  • Prestige Consumer Healthcare's Accounts Payables rose 12016.82% to $42.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $42.9 million, marking a year-over-year increase of 12016.82%. This contributed to the annual value of $18.9 million for FY2025, which is 5144.82% down from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Accounts Payables of $42.9 million as of Q4 2025, which was up 12016.82% from $41.9 million recorded in Q3 2025.
  • Prestige Consumer Healthcare's Accounts Payables' 5-year high stood at $64.3 million during Q4 2022, with a 5-year trough of $18.9 million in Q1 2025.
  • Its 5-year average for Accounts Payables is $42.4 million, with a median of $41.0 million in 2021.
  • Examining YoY changes over the last 5 years, Prestige Consumer Healthcare's Accounts Payables showed a top increase of 12016.82% in 2025 and a maximum decrease of 5144.82% in 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Accounts Payables (Quarter) stood at $40.1 million in 2021, then soared by 60.22% to $64.3 million in 2022, then plummeted by 38.78% to $39.3 million in 2023, then tumbled by 50.42% to $19.5 million in 2024, then soared by 120.17% to $42.9 million in 2025.
  • Its last three reported values are $42.9 million in Q4 2025, $41.9 million for Q3 2025, and $22.2 million during Q2 2025.